Literature DB >> 7354052

Characterization of a unique human apolipoprotein E variant associated with type III hyperlipoproteinemia.

V I Zannis, J L Breslow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7354052

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  19 in total

Review 1.  Pharmacogenetics of target genes across the warfarin pharmacological pathway.

Authors:  Suman Lal; Srinivasa Rao Jada; Xiaoqiang Xiang; Wan-Teck Lim; Edmund J D Lee; Balram Chowbay
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Apolipoprotein (apo) E genotypes by polymerase chain reaction and allele-specific oligonucleotide probes: no detectable linkage disequilibrium between apo E and apo CII.

Authors:  R S Houlston; C Snowden; F Green; K G Alberti; S E Humphries
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

3.  [Apolipoproteinopathies].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1983-02-15

Review 4.  Apolipoprotein E.

Authors:  V I Zannis; J L Breslow
Journal:  Mol Cell Biochem       Date:  1982-01-16       Impact factor: 3.396

5.  Apolipoprotein E synthesis in human kidney, adrenal gland, and liver.

Authors:  M L Blue; D L Williams; S Zucker; S A Khan; C B Blum
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

6.  Baculovirus-mediated expression of human apolipoprotein E in Manduca sexta larvae generates particles that bind to the low density lipoprotein receptor.

Authors:  D G Gretch; S L Sturley; P D Friesen; N E Beckage; A D Attie
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

7.  Genetics of the apolipoprotein-E isoprotein system in man.

Authors:  A M Cumming; F W Robertson
Journal:  J Med Genet       Date:  1982-12       Impact factor: 6.318

8.  Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.

Authors:  S C Rall; K H Weisgraber; T L Innerarity; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

9.  Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.

Authors:  R W Milne; P K Weech; L Blanchette; J Davignon; P Alaupovic; Y L Marcel
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

10.  Apolipoprotein E and cholesterol metabolism.

Authors:  R W Mahley
Journal:  Klin Wochenschr       Date:  1983-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.